BerGenBio ASA: Exercise price in the last exercise period for warrants issued in connection with rights issue
Bergen, Norway, 27 March 2024 – Reference is made to the stock exchange announcement from BerGenBio ASA (the "Company") dated 14 June 2023 regarding the final results of the rights issue of 2,500,000,000 new shares in the Company (the "Offer Shares"), raising gross proceeds of NOK 250 million (the "Rights Issue"), and the allocation and issuance to subscribers in the Rights Issue of one warrant for every two Offer Shares allocated to them and paid by them in the Rights Issue (the "Warrants"). As announced on 14 June 2023, the Company issued 1,249,999,617 Warrants of which 1,181,842,935